©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 113463
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113463
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113463
Table 4 Quality of life and anxiety by proton pump inhibitor type
| PPI type | Improved QoL (%) | Anxiety (%) |
| Omeprazole | 42% | 18% |
| Esomeprazole | 40% | 17% |
| Lansoprazole | 61% | 9% |
| Pantoprazole | 44% | 16% |
| Dexlansoprazole | 47% | 14% |
- Citation: Sawaied IO, Samson AO, Golan E. Patients’ perception of proton pump inhibitors use and their risks. World J Clin Oncol 2026; 17(1): 113463
- URL: https://www.wjgnet.com/2218-4333/full/v17/i1/113463.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i1.113463